Inactive Instrument

Apotheca Biosciences, Inc. Stock

Equities

CBDC

US03836L1070

Biotechnology & Medical Research

Dynamic Chart
Apotheca Biosciences, Inc. cancelled the acquisition of 51% of Hemp Bloom LLC. CI
Apotheca Biosciences, Inc. Announces Resignation of P.C. Sundareswaran as the Chairman and CEO CI
Deirdre Fernandes Resigns as VP of Operations and Director of Apotheca Biosciences, Inc CI
Apotheca Biosciences, Inc. signed a definitive agreement to acquire 51% of Hemp Bloom LLC. CI
Apotheca Biosciences, Inc. Reports Earnings Results for the First Quarter Ended April 30, 2019 CI
Apotheca Biosciences Introduces XKAPE by ProMED, Newest Product Line Designed for Independent Grocers & Convenience Stores CI
Apotheca Biosciences, Inc. Announces Resignation of Verghese from Chief Technical Officer and Director CI
Apotheca Biosciences, Inc. will Change its Ticker to CBDC from PCFP CI
Apotheca Biosciences Announces the Incorporation of Its Newly Created Subsidiary ProMED Biosciences, Inc CI
Apotheca Biosciences, Inc. Appoints P.C. Sundar as its Chairman & CEO CI
Apotheca Biosciences Introduces ProMED CI
Apotheca Biosciences, Inc. Announces Management Changes CI
Apotheca Biosciences Signs an LOI For Purchase of Nano Creaciones S.A. P.I. de C.V CI
Apotheca Biosciences Announces Addition of Dr. Herbert Weissbach to the Cannabis Scientific Advisory Board CI
Apotheca Biosciences Announces the Addition of Malireddy Srinivasulu Reddy to its Research Team as Chief Medical Advisor CI
More news
Apotheca Biosciences, Inc., formerly Cannabis Leaf Inc., is a medical device company. The Company is developing engineering and device solutions for cannabinoid medical technologies. It is focused on developing medical products and nutraceuticals and formulates and delivers technologies. The Company serves healthcare and consumer care industry. The Company's products include transdermal and sublingual. It also provides nasal delivery technologies for precise and controlled dosing of cannabinoids. Its pipeline products includes, transdermal, sublingual, and nasal delivery technologies.
More about the company